课题基金 / 基金详情

Immune interactions with commensal microbes in early life

Immune interactions with commensal microbes in early life
生命早期与共生微生物的免疫相互作用
批准号:
10567936
负责人:
CHYI S HSIEH
金额:
$71.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-11-02 至 2027-10-31

项目摘要

项目成果

CHYI S HSIEH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Events in early life, particularly those altering the gut microbiota and immune development, can have an important role in determining future risk of immune related disorders. For example, it has been reported that the how substances are encountered by the immune system, the timing of feeding practices, hygiene, and the use of antibiotics, in early life can modify the risk of immune driven disorders later in life. A common theme amongst many of these studies is that these risk factors likely affect the developing microbiota. However, the biologic basis for how early life microbial changes can affect the risk of immune disorders later in life is incompletely understood. Previous data from our laboratories have suggested that during this preweaning period, specific live gut bacteria are selectively delivered to the immune system and that interaction of these live bacteria with cellular immune populations locally in the colonic lamina propria or in distant lymphoid tissues establishes a durable (life- long) and balanced immune system. In preliminary studies, we observed substantial variance in the amount of bacterial translocation in this preweaning period, which was corroborated with studies of antigen-specific T cell responses to a translocating bacterial spp. We therefore hypothesize that the magnitude and quality of the immune response to these translocating bacteria species during the preweaning period is a stochastic event during normal ontogeny which represents an important variable in determining whether an individual establishes a balanced immune system and prevents immune mediated pathologies in later life. However, the nature of these translocating bacteria and methods to quantify the antigen-specific responses to these bacteria remain a gap in our knowledge. We will address this question by identifying and characterizing how the translocating bacteria are encountered by the immune system (Aim 1) and generate reagents to track bacterial antigen presentation via T cell responses in vivo (Aim 2). We will use these reagents to integrate the immune response over the preweaning period to translocating bacterial spp. during physiologic development and correlate it with intestinal immune challenges including infection and experimental colitis in later life (Aim 3). If successful, this project may reveal that preweaning translocation is an important stochastic developmental variable involved in generating intestinal immune health and homeostasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CAR-T cell treatment of CNS Autoimmunity
  • 批准号:
    10641913
  • 项目类别:
  • 资助金额:
    $68.34万
  • 财政年份:
    2022
  • 负责人:
    CHYI S HSIEH
  • 依托单位:
CAR-T cell treatment of CNS Autoimmunity
  • 批准号:
    10539779
  • 项目类别:
  • 资助金额:
    $67.19万
  • 财政年份:
    2022
  • 负责人:
    CHYI S HSIEH
  • 依托单位:
B cell-targeted CAR-T treatment of CNS Autoimmunity
  • 批准号:
    10514950
  • 项目类别:
  • 资助金额:
    $23.63万
  • 财政年份:
    2022
  • 负责人:
    CHYI S HSIEH
  • 依托单位:
B cell-targeted CAR-T treatment of CNS Autoimmunity
  • 批准号:
    10677698
  • 项目类别:
  • 资助金额:
    $19.44万
  • 财政年份:
    2022
  • 负责人:
    CHYI S HSIEH
  • 依托单位:
海外基金